📖
EQD2-adjusted mean lung dose and symptomatic pneumonitis after thoracic radiotherapy following immune checkpoint inhibitors in lung cancer: a single-center retrospective cohort study.
Li X, Liu L, Zheng N, Wang N, Xiao T, Lin X, Chen H, Shi Q, Le Y

EQD2-adjusted mean lung dose and symptomatic pneumonitis after thoracic radiotherapy following immune checkpoint inhibitors in lung cancer: a single-center retrospective cohort study.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Front Oncol.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title EQD2-adjusted mean lung dose and symptomatic pneumonitis after thoracic radiotherapy following immune checkpoint inhibitors in lung cancer: a single-center retrospective cohort study.
Author / Organization Li X, Liu L, Zheng N, Wang N, Xiao T, Lin X, Chen H, Shi Q, Le Y
Subject & Discipline Front Oncol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-31871
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »